Recent news on Oral Transmucosal Fentanyl Citrate

Sosei Announces Successful Completion of AD 923  -  May 23, 2007
PipelineReview.com (press release),...single dose, crossover, randomised study of AD 923 versus Actiq® (oral transmucosal fentanyl citrate lozenge) and versus fentanyl citrate injection.

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  Apr 25, 2007
MSN MoneyACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  26 Apr 2007
MSN MoneyACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon Files Marketing Application for Approval of a Fentanyl ...  -  Mar 29, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; numerous products are marketed internationally.

Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application  -  Apr 3, 2007
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon Files Marketing Application For Approval Of A Fentanyl ...  -  27 Mar 2007
Medical News Today (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; numerous products are marketed internationally.

Market Report -- In Play (CEPH)  -  Mar 8, 2007
MSN Money2007, CEPH received a letter requesting information related to ACTIQ (oral transmucosal fentanyl citrate) and FENTORA (fentanyl buccal tablet) from

Schmidt & Clark, LLP Contacted by Actiq Users Claiming Off-Label Use  -  Feb 24, 2007
PR Leap (press release),Approved by the US Food & Drug Administration (FDA) in 1998, Actiq (oral transmucosal fentanyl citrate) is a prescription medication indicated ONLY for the

Cephalon, Inc. Promotes Mike Barr to Vice President  -  Feb 12, 2007
Drug Newswire (press release),FENTORA, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection,

Cephalon, Inc. Promotes Mike Barr to Vice President  -  Feb 7, 2007
Yahoo! News (press release)FENTORA, ACTIQ® (oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic trioxide) injection, and VIVITROL®

Cephalon Reports Record Sales and Earnings for 2006  -  Feb 15, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and numerous products internationally.

Cephalon Announces Positive Results from Two Phase 3 Clinical ...  -  Jan 9, 2007
Yahoo! News (press release)...when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq®), to FENTORA,

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of ...  -  Dec 4, 2006
Yahoo! News (press release)FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ® (oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic

Cephalon Inc. Granted Composition of Matter Patent Covering ...  Nov 7, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire (press release), Cephalon Announces Positive Results For FENTORA(TM) (fentanyl ...  Oct 12, 2006
...bioavailability of fentanyl in FENTORA, when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq ... -Medical News Today (press release), Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire

Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of ...  -  Dec 4, 2006
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of ...  -  Dec 4, 2006
Yahoo! News (press release)FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ® (oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire

Effectiveness of Fentanyl lozenges for breakthrough cancer pain  Aug 8, 2006
...medicine. The Fentanyl lozenge, known as oral transmucosal Fentanyl citrate, or OTFC, is also known by the brand name Actiq. The ... -Xagena.it

Cephalon Second-Quarter Sales Increase 58 Percent  Aug 3, 2006
...of $380-390 million, driven largely by strong gross sales of PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -MSN Money

Cephalon Second-Quarter Sales Increase 58 Percent  Aug 3, 2006
...of $380-390 million, driven largely by strong gross sales of PROVIGIL® (modafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... -Yahoo! News

Cephalon Expects Second Quarter 2006 Results to Exceed Prior ...  Jul 26, 2006
...by at least 40 percent driven largely by strong gross sales of PROVIGIL® (modafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl ...  Jun 29, 2006
...the license and supply agreement with the company to have Cephalon manufacture for it a generic version of ACTIQ® (oral transmucosal fentanyl citrate) [C- II ... -Yahoo! News

Advances in the Pharmacologic Treatment of Chronic and ...  Jun 29, 2006
...of FEBT and found that this formulation provides more rapid and efficient delivery of fentanyl than oral transmucosal fentanyl citrate or swallowed FEBT. ... -Medscape (subscription)

Cephalon Receives Approvable Letter From FDA For FENTORA - Update  Jun 29, 2006
...the license and supply agreement with the company to have Cephalon manufacture for it a generic version of ACTIQ (oral transmucosal fentanyl citrate) (C- II ... -Trading Markets

Cephalon Announces Results from GABITRIL(R) Clinical Program in ...  Jun 26, 2006
...markets five proprietary products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL, ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon Announces Results from GABITRIL(R) Clinical Program in ...  Jun 26, 2006
...markets five proprietary products in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire



Cephalon's Fentanyl Effervescent Buccal Tablet Reduces Intensity ...  May 5, 2006
...in the United States: PROVIGIL(R) (modafinil) tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and ... - Medical News Today

Cephalon Reports First-Quarter Financial Results  May 2, 2006
...products in the United States: PROVIGIL (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon Receives Approvable Letter for NUVIGIL(TM) (armodafinil)  May 1, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)  Apr 24, 2006
...products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)  Apr 24, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and ... - PR Newswire





Cephalon Oncology Compound Lestaurtinib (CEP-701) Granted Orphan ...  Apr 4, 2006
...in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride) Tablets, ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon Oncology Compound Lestaurtinib (CEP-701) Granted Orphan ...  Apr 4, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride) Tablets, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - PharmaLive.com

Cephalon Granted Six Months of Pediatric Exclusivity for PROVIGIL  Mar 28, 2006
...four proprietary products in the United States: PROVIGIL, GABITRIL(R) (tiagabine hydrochloride) Tablets, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - PharmaLive.com



Cephalon Reports Outstanding Financial Results for 2005  Feb 14, 2006
In 2005, sales of PROVIGIL® (modafinil) Tablets [C-IV] increased 17 percent to $512.8 million; sales of ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon, Inc. Announces Agreements With Barr Laboratories, Inc. ...  Feb 1, 2006
...patent infringement disputes in the United States related to PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... - Black Enterprise,

Cephalon, Inc. Provides Update on Regulatory Status of NUVIGIL(TM)  Feb 1, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... - Yahoo! News

Studies Confirm Effectiveness Of Fentanyl Lozenges For ' ...  Jan 25, 2006
...medicine. The fentanyl lozenge, known as oral transmucosal fentanyl citrate, or OTFC, is also known by the brand name Actiq. The ... - Medical News Today

Barr Announces Agreements with Cephalon, Inc. Regarding Settlement ...  Feb 1, 2006
...agreements to settle its pending patent infringement disputes in the United States related to Cephalon's ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - PR Newswire

Cephalon, Inc. Provides Update on Regulatory Status of NUVIGIL  Feb 2, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - PharmaLive.com

Cephalon, Inc. Announces Agreements With Barr Laboratories, Inc. ...  Feb 1, 2006
...patent infringement disputes in the United States related to PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... - Black Enterprise

Horst Witzel, Dr.-Ing., to Retire From Cephalon Board of Directors  Jan 31, 2006
...products in the United States: PROVIGIL(R) (modafinil) [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and ... - PR Newswire

Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)  Jan 25, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... - Yahoo! News

Horst Witzel, Dr.-Ing., to Retire From Cephalon Board of Directors  Jan 31, 2006
...products in the United States: PROVIGIL® (modafinil) [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional